DICER1 and cancer: Dicer was consistently expressed at high levels in the majority of metastatic (55.8%), acrolentiginous (55.0%) and cutaneous (46.4%) melanomas compared to mucosal melanoma (12.5%), conferring further cancer-cell specificity among different types of melanomas (Table 1).